Sareum Ltd. Release: Extension Of Collaboration With Almirall Prodesfarma

Published: Jul 13, 2006

Sareum Holdings plc (AIM: SAR), the specialist structure-based drug discovery and services business, and Almirall Prodesfarma S.A. ("Almirall"), the leading Spanish multinational pharmaceutical company, are pleased to announce that they have extended their collaborative agreement for Sareum to provide protein structure determination capabilities to accelerate drug discovery research at Almirall.

Back to news